Sanford Health and the Good Samaritan Society partner
To improve senior services in the Bismarck-Mandan area, Sanford Health and the Good Samaritan Society are combining expertise and resources to create a joint venture. As part of this partnership, a 120-bed rehabilitation/skilled care center is being built in southeast Mandan. The joint venture will also include existing Sanford Health Continuing Care Centers in Bismarck-Mandan […]
⋅ 5 min read
Sanford physician helps develop new chemotherapy treatment
A drug that blocks neurotransmitters could reduce nausea and vomiting caused by chemotherapy, research co-authored by a Sanford Health physician and published in the New England Journal of Medicine finds. Sanford oncologist and cancer researcher Steven Powell, M.D., was among a team of researchers who discovered that the drug olanzapine, which is FDA approved for […]
⋅ 3 min read
$500,000 gift to benefit Sanford Children’s Hospital NICU
Mark and Claudia Thompson are announcing a $500,000 gift to the Sanford Health Foundation. The generous donation will benefit Sanford Children’s Hospital Neonatal Intensive Care Unit (NICU) in Bismarck. The Thompsons are the owners of Bismarck based H.A. Thompson & Sons, a plumbing, heating, air conditioning and mechanical contractor servicing North Dakota, South Dakota, Minnesota […]
⋅ 3 min read
Sanford scientist models development disorder in stem cells
Studies performed by a Sanford Research scientist using an innovative stem-cell model for a fatal developmental disorder is the focus of a recent study published in Nature Medicine. Kevin Francis, Ph.D. uncovered unique cellular defects associated with Smith-Lemli-Opitz syndrome (SLOS) by modeling this disease using induced pluripotent stem cells. Francis’ study is titled “Modeling Smith-Lemli-Opitz […]
⋅ 2 min read
Sanford scientists create animal model for brain tumor
Sanford Research scientists are published in Nature Cell Biology for their work developing a model to explore therapies for a pediatric brain tumor known as choroid plexus carcinoma. Haotian Zhao, Ph.D., is the lead author on the study titled “Sonic Hedgehog promotes proliferation of Notch-dependent monociliated choroid plexus tumour cells.” Zhao is an associate scientist […]
⋅ 2 min read
Body’s own cells are focus of type 1 diabetes clinical trial
Sanford Health is collaborating with Caladrius Biosciences, Inc., a New Jersey-based cell-therapy company, on a clinical trial that explores whether increasing the number of a person’s regulatory T cells (Treg cells) can help adolescents fight newly onset type 1 diabetes. The trial, known as “The Sanford Project: T-Rex Study” (NCT02691247), tests the safety and effectiveness […]
⋅ 5 min read
Profile by Sanford passes 1 million pounds lost milestone
Sanford Health’s weight management system has helped its members lose more than 1 million pounds. Profile by Sanford’s members, which now total nearly 50,000, reached the milestone across its 25 locations in 10 states. Built on clinical research and advisory oversight from Sanford physicians and researchers, Profile uses meal-replacement products, nutritionally complete food and health […]
⋅ 4 min read
Sanford Health eyes more growth in Ghana
Sanford Health has more than doubled its locations in Ghana in the past three months thanks to a public-private partnership with the national government in the African country. Ghana Health Services recently transitioned 12 of its facilities in the Central and Western Regions of Ghana to Sanford World Clinics. These locations were operating under the […]
⋅ 4 min read
Cancer clinical trial aims to activate immune system
A new Sanford Health clinical trial will explore a drug’s ability to activate the body’s immune system to fight head and neck cancer. Oncologist and cancer researcher Steven Powell, M.D., developed and will lead the Merck Investigator Studies Program (MISP) trial using the investigational drug pembrolizumab in combination with chemotherapy and radiation therapy for participants […]
⋅ 4 min read
Clinical trials: ‘Increased treatment options’
David Pearce, president of Sanford Research, recently talked to MED Magazine about clinical trials.
⋅ 2 min read
